Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Dr. Goepfert joined the UAB faculty in 1997, is board-certified in Medicine and Infectious Diseases and is licensed to practice medicine in Alabama. His research interests are focused on T cell immunology and vaccine design. He has published numerous papers detailing HIV-specific CD8 and CD4 T cell immune responses in HIV-infected patients. His laboratory was one of the first to demonstrate the relative functional deficiencies of HIV-specific CD8 T cells and the importance of targeting the Gag protein. Recently he demonstrated that peptides, derived from antisense transcripts, are able to induce responses to HIV. His laboratory is also adept in a number of assays that measure antigen specific T cells including the 51chromium-release assay, IFN-g ELISPOT, multiplex cytokine analysis, and polyfunctional flow cytometry (PFC). He has performed this work via NIH funding sources for the last 12 years.
HIV Vaccine; Adenovirus 35; Adenovirus 5; DNA vaccine; Randomized clinical trial
Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 